NCT03547115
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03547115
Title A Phase 1 Study of Voruciclib in Subjects With B-Cell Malignancies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors MEI Pharma, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Northwestern Memorial Hospital Chicago Illinois 60611 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198 United States Details
New York University New York New York 10016 United States Details
Duke University Durham North Carolina 27705 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
MD Anderson Houston Texas 77030 United States Details
University of Virginia Charlottesville Virginia 22903 United States Details
Swedish Cancer Institute Seattle Washington 98104 United States Details
Froedtert Hospital & the Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field